Vaxxinity

VAXX

Q4 FY2023 Earnings

Financial report interval: 2023.10.01 - 2023.12.31

Overview: Vaxxinity(VAXX) the EBIT is -11.65 M (+44.05%);the EPS is -0.0895 (+44.82%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.01B44.05%
----
----
EPS
-0.089544.82%
----
----

Revenue

ActualEstimateUnit: USD
Quarterly

EBIT

ActualEstimateUnit: USD
Quarterly

Net income

ActualEstimateUnit: USD
Quarterly

EPS

ActualEstimateUnit: USD
Quarterly